Grade 3 bone marrow fibrosis in newly diagnosed multiple myeloma
MRIMS Journal of Health Sciences · 20.07.2026
DOI: 10.4103/mjhs.mjhs_44_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift MRIMS Journal of Health Sciences, online erschienen am 20.07.2026. Verfasst von Bharti Mehla und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Multiple myeloma (MM) is a plasma cell dyscrasia with clonal proliferation of malignant plasma cells within the bone marrow. In newly diagnosed myeloma, bone marrow fibrosis (BMF) is an uncommon and clinically intriguing finding. The presence and severity of BMF influence disease biology, treatment response, and overall survival outcomes as observed in recent studies. Despite this, it remains unincorporated in current staging systems. We report a 63-year-old male who presented with weakness, weight loss, altered sensorium, anemia, renal failure, and hypercalcemia. Bone marrow biopsy revealed diffuse plasma cell infiltration with Grade 3 reticulin fibrosis, and investigations confirmed immunoglobulin g lambda MM with high-risk cytogenetic abnormalities. The patient was started on cyclophosphamide, bortezomib, and dexamethasone induction therapy, but after one cycle, discontinued standard treatment in favor of complementary therapy and died 4 weeks later. This case highlights severe BMF as a potential adverse prognostic marker in newly diagnosed MM.
Zitieren
APA
Mehla, B., Bishnoi, A., Gupta, M., Gupta, M., & Tahlan, A. (2026). Grade 3 bone marrow fibrosis in newly diagnosed multiple myeloma. MRIMS Journal of Health Sciences. https://doi.org/10.4103/mjhs.mjhs_44_26
Vancouver
Mehla B, Bishnoi A, Gupta M, Gupta M, Tahlan A. Grade 3 bone marrow fibrosis in newly diagnosed multiple myeloma. MRIMS Journal of Health Sciences. 2026. doi:10.4103/mjhs.mjhs_44_26
BibTeX
@article{Mehla2026,
author = {Mehla, Bharti and Bishnoi, Aayush and Gupta, Monica and Gupta, Muskan and Tahlan, Anita},
title = {Grade 3 bone marrow fibrosis in newly diagnosed multiple myeloma},
journal = {MRIMS Journal of Health Sciences},
year = {2026},
doi = {10.4103/mjhs.mjhs_44_26}
}
EUVIMED